Navigation Links
2011 FEBS/EMBO Women in Science Award honors Carol V. Robinson
Date:2/17/2011

Heidelberg, 17 February 2011 The European Molecular Biology Organization (EMBO) and the Federation of European Biochemical Societies (FEBS) announce Carol V. Robinson, Professor of Chemistry at the University of Oxford, UK, as the winner of the 2011 FEBS/EMBO Women in Science Award. Professor Robinson has been recognized for her pioneering work in the development of mass spectrometry as a tool used for investigating the structure and dynamics of protein complexes.

The FEBS/EMBO Women in Science Award rewards the exceptional achievements of a female researcher in molecular biology over the previous five years. Winners of the award are role models who inspire future generations of women in science.

"Carol V. Robinson has pioneered, in an almost single-handed manner, the use of electrospray mass spectrometry for structural studies of large multimeric protein assemblies. She had the courage to do what experts regarded as not feasible and has succeeded in the face of strong skepticism," stated her collaborator Wolfgang Baumeister from the Max Planck Institute of Biochemistry in Martinsried, Germany, in his nomination of Carol Robinson for the award.

"I am truly delighted that the work of my research group has been honoured in this way," said Carol Robinson upon hearing of the award. "Women from many continents and countries are employed in my group. They have enriched my research bringing different talents and skills."

Robinson's research has opened up a new area of mass spectrometry. Her group was one of the first to use electrospray mass spectrometry to study large protein complexes. In collaboration with Micromass UK, she designed an instrument specifically adapted for the detection of high-mass complexes. This instrument has since gone into production in Canada and the UK and has now been installed in many laboratories around the world. More recently, her research has focused on combining mass spectrometry with cryoelectron microscopy.

The 2011 winner is distinguished not only for her scientific contributions, but also for her support and mentoring of women pursuing careers in science. As a group leader, Carol understands the importance of a flexible workplace for the scientists in her lab who are parents.

Her own career path was marked by her early start as a laboratory technician for seven years before obtaining a PhD. She then took an eight-year break to raise her three children. She returned to the lab as a post doctoral researcher, built her research group, and became the first female professor of chemistry at Cambridge University in 2001. Three years later, she was made a Fellow of the Royal Society and was awarded the Royal Society's Rosalind Franklin Award that promotes women in science, technology, engineering and mathematics.

The 2011 FEBS/EMBO Women in Science Award of 10,000 euros will be presented to Carol V. Robinson on 28 June at the 36th FEBS Congress in Torino, Italy, where she will present a special lecture.


'/>"/>

Contact: Suzanne Beveridge
suzanne.beveridge@embo.org
49-622-188-91108
European Molecular Biology Organization
Source:Eurekalert

Related biology news :

1. 2010 FEBS/EMBO Women in Science award honors Ingrid Grummt
2. Women do not recover their muscle strength as fast as men
3. Brown University and Women & Infants Hospital expand national childrens study to Bristol County
4. Vitamin K does not stem BMD decline in postmenopausal women with osteopenia
5. Study: Elderly Women can increase strength but still risk falls
6. Pregnant women consuming flaxseed oil have high risk of premature birth
7. 17th Annual Congress on Womens Health convenes
8. Pregnant women with asthma can be more confident about some medicines
9. Men are red, women are green, Brown researcher finds
10. Statin warning for pregnant women
11. Long-term use of diabetes drugs by women significantly increases risk of fractures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... -- Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... its quarter and year ended December 31, 2016. ... million compared to $6.9 million in the same quarter last ... $0.6 million compared to $2.6 million in the fourth quarter ... was $0.5 million, or $0.02 per diluted share, which compares ...
(Date:2/8/2017)... -- Report Highlights The global biosurgery market ... in 2016 at a compound annual growth rate (CAGR) ... - An overview of the global market for biosurgery. ... 2015 and 2016, and projections of compound annual growth ... on the basis of product type, source, application, and ...
(Date:2/7/2017)... 2017 Ipsidy Inc. ( www.ipsidy.com ... IDGS], ("Ipsidy" or the "Company") a provider of secure, ... is pleased to announce the following changes as part ... January 31, 2017, Philip D. Beck was ... President.  An experienced payment industry professional and public company ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... 24, 2017 Symic Bio, a biopharmaceutical company ... category of therapeutics, announced today the completion of enrollment ... artery disease. The trial will evaluate the safety and ... the reduction of restenosis following angioplasty. ... for SB-030," said Nathan Bachtell , M.D., Chief ...
(Date:2/24/2017)... Corporation (NASDAQ: VWR), the leading global independent provider of product ... its financial results for the fourth quarter and full year ... 4Q16 record quarterly net sales of $1.13 billion, up ... 4Q16 EMEA-APAC segment net sales increased ... net sales increased 2.5%, or down 0.9% on an organic ...
(Date:2/23/2017)... Feb. 23, 2017 /PRNewswire/ - The Fight Against Cancer ... Research (OICR) are pleased to report that Fusion Pharmaceuticals ... with Johnson & Johnson Innovation – JJDC, Inc. (JJDC) ... groups HealthCap, TPG Biotechnology Partners, and Genesys Capital, as ... ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... de novo clearance to begin marketing the SPEAC® System, the Brain Sentinel® Seizure ... at home or in healthcare facilities during periods of rest. A lightweight, non-invasive ...
Breaking Biology Technology: